Mineralys outlines lorundrostat U.S. launch plans ahead of December 22, 2026 PDUFA
Mineralys Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $31.11
-10% in 7d after detection
Post-detection moves
1h
—
1d
+0.6%
3d
-0.3%
7d
-10%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS